Polar Securities »

Iovance Biotherapeutics shares owned by Polar Securities

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Polar Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 138k 8.13
2023-09-30 $1.0M 224k 4.55
2023-06-30 $2.8M 397k 7.04

More positions owned by Polar Securities

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United States Stl Corp Note 5.000%11/0 (Principal)
Intuitive Surgical Com New (ISRG)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ati Note 3.500% 6/1 (Principal)
Interdigital Note 3.500% 6/0 (Principal)
Bloomin Brands Note 5.000% 5/0 (Principal)
Ormat Technologies Note 2.500% 7/1 (Principal)
Boston Scientific Corporation (BSX)
Ishares Tr Ishares Semicdtr Put Option (SOXX)
Post Hldgs Note 2.500% 8/1 (Principal)
Sony Group Corp Sponsored Adr Put Option (SONY)

View all positions for Polar Securities

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics